Study Evaluating Efficacy and Safety of FFX Versus Combination of CPI-613 With mFFX in Patients With Metastatic Adenocarcinoma of the Pancreas
Public ClinicalTrials.gov record NCT03504423. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III Multicenter Open-label Randomized Trial to Evaluate Efficacy and Safety of Folfirinox (FFX) Versus Combination of CPI-613 With Modified Folfirinox (mFFX) in Patients With Metastatic Adenocarcinoma of the Pancreas
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
A prospective, multicenter, open label, randomized phase III study to evaluate efficacy and safety of FFX versus CPI-613 + mFFX in patients with metastatic adenocarcinoma of the pancreas with age range of 18 to 75 years
Study identification
- NCT ID
- NCT03504423
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 528 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 9, 2018 (Actual)
- Primary completion
- Aug 16, 2021 (Actual)
- Completion
- Jan 2, 2022 (Actual)
- Last update posted
- Jan 3, 2023
2018 – 2022
United States locations
- U.S. sites
- 40
- U.S. states
- 24
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner MD Anderson Cancer Center | Gilbert | Arizona | 85234 | — |
| The University of Arizona Cancer Center | Tucson | Arizona | 85724 | — |
| City of Hope | Duarte | California | 91010 | — |
| USC Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | — |
| UCLA Medical Center | Los Angeles | California | 90404 | — |
| Pacific Hematology Oncology Associates | San Francisco | California | 94115 | — |
| Smilow Cancer Hospital at Yale-New Haven | New Haven | Connecticut | 06511 | — |
| Georgetown University Medical Center | Washington D.C. | District of Columbia | 20007 | — |
| Mayo Clinic Hospital | Jacksonville | Florida | 32224 | — |
| Mount Sinai Medical Center | Miami Beach | Florida | 33140 | — |
| Northwestern Memorial Hospital - Arkes Family Pavilion | Chicago | Illinois | 60611 | — |
| University of Chicago | Harvey | Illinois | 60426 | — |
| The University of Kansas Cancer Center - Clinical Research Center - Fairway Office Park | Fairway | Kansas | 66205 | — |
| University of Massachusetts Memorial Medical Center | Worcester | Massachusetts | 01655 | — |
| University of Micihgan | Ann Arbor | Michigan | 48109 | — |
| Karmanos cancer Center | Detroit | Michigan | 48201 | — |
| Mayo Clinic Cancer Center (MCCC) | Rochester | Minnesota | 55905 | — |
| Washington University | St Louis | Missouri | 63110 | — |
| Comprehensive Cancer centers of Nevada | Las Vegas | Nevada | 89148 | — |
| Englewood Hospital and Medical Center | Englewood | New Jersey | 07631 | — |
| Atlantic Health System | Morristown | New Jersey | 07962 | — |
| University of New Mexico Cancer Center | Albuquerque | New Mexico | 87102 | — |
| Roswell Park Cancer Institute | Buffalo | New York | 14263 | — |
| New York University Langone Medical Center | New York | New York | 10016 | — |
| Stony Brook University Hospital | Stony Brook | New York | 11794 | — |
| UNC Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599 | — |
| Levine cancer Institute | Charlotte | North Carolina | 28204 | — |
| Wake Forest Baptist Health | Winston-Salem | North Carolina | 27157 | — |
| University of Cincinnati Cancer Institute | Cincinnati | Ohio | 45267 | — |
| Cleveland Clinic - Taussig Cancer Center | Cleveland | Ohio | 44106 | — |
| University Hospitals - Seidman Cancer Center | Cleveland | Ohio | 44106 | — |
| Oregon Health and Science University | Portland | Oregon | 97239 | — |
| University of Pittsburgh-Hillman cancer ceter | Pittsburgh | Pennsylvania | 15232 | — |
| Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center-Henry-Joyce Cancer Clinic | Nashville | Tennessee | 37232 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Huntsman cancer Institute | Salt Lake City | Utah | 84112 | — |
| University of Virginia Cancer Center - Emily Couric Clinical Cancer Center | Charlottesville | Virginia | 22908 | — |
| VCU Massey Cancer Center | Richmond | Virginia | 23298 | — |
| Blue Ridge Cancer Care | Roanoke | Virginia | 24014 | — |
| Seattle Cancer Care Alliance | Seattle | Washington | 98109 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03504423, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 3, 2023 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03504423 live on ClinicalTrials.gov.